Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase.

Acta anaesthesiologica Scandinavica - 1 Apr 1993

Ostergaard D, Jensen F S, Jensen E, Skovgaard L T, Viby-Mogensen J

Abstract excerpt

The duration of action of mivacurium was evaluated during a modified neurolept anaesthesia in 17 patients heterozygous for the usual and the atypical plasma cholinesterase (pChe) gene (E1uE1a) and in five patients homozygous for the atypical gene (E1aE1a). The response to train-of-four nerve stimulation was recorded using a Myograph 2000. Five heterozygous patients were given a small dose of mivacurium 0.03 mg kg...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged
Share to Heterozygote

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Homozygote

Share to Muscle Contraction

Share to Phenotype

Share to Reaction Time

Share to Synaptic Transmission

Source

Identifiers

PMID: 8390770
DOI: 10.1111/j.1399-6576.1993.tb03721.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase.PMID 8390770Read ↗

Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant: effect of injection of human cholinesterase.Semantic proximity Read ↗

Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA).Semantic proximity Read ↗

Dose-response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity.Semantic proximity Read ↗

Markedly prolonged paralysis after mivacurium in a patient apparently heterozygous for the atypical and usual pseudocholinesterase alleles by conventional biochemical testing.Semantic proximity Read ↗

Prolonged mivacurium neuromuscular block in children.Semantic proximity Read ↗

Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients.Semantic proximity Read ↗

Mivacurium sensitivity in a patient heterozygous for the atypical and silent genes for plasma cholinesterase.Semantic proximity Read ↗

Pretreatment with pancuronium before suxamethonium administration in patients heterozygous for the usual and the atypical plasma cholinesterase gene.Semantic proximity Read ↗

Plasma cholinesterase activity and duration of action of mivacurium in phenotypically normal patients.Semantic proximity Read ↗

Response to mivacurium in patients carrying the k variant in the butyrylcholinesterase gene.Semantic proximity Read ↗

Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene: genotyping by sequencing.Semantic proximity Read ↗

Clinical importance of plasma cholinesterase for the anaesthetist.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.